Actively Recruiting

Age: 18Years +
FEMALE
Healthy Volunteers
NCT06639763

Erectile Aid Use in Post-phalloplasty and Post-metoidioplasty Transgender Patients

Led by University Hospital, Ghent · Updated on 2024-10-15

1000

Participants Needed

1

Research Sites

51 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study seeks to explore the various methods used by transgender men for sexual intercourse following phalloplasty or metoidioplasty, focusing on their satisfaction with different erectile aids, as well as the satisfaction of their partners. Phalloplasty and metoidioplasty are gender-affirming surgeries that often require additional aids to achieve the desired sexual function, particularly for penetration. While internal erectile prostheses are common after phalloplasty, they come with high complication rates, leading some patients to opt for non-surgical aids. However, the effectiveness and comfort of these aids are not well-documented. This study aims to fill this gap by examining the types of aids transgender men use, how well these aids meet their sexual needs, and how satisfied both they and their partners are with the outcomes, providing much-needed insight for healthcare providers and patients alike.

CONDITIONS

Official Title

Erectile Aid Use in Post-phalloplasty and Post-metoidioplasty Transgender Patients

Who Can Participate

Age: 18Years +
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient and partner age 63 18 years.
  • Transgender or gender non-conforming individuals (and their partners).
  • Patients have undergone phalloplasty or metoidioplasty as a form of genital gender affirming surgery.
  • At least 6 months after phalloplasty or metoidioplasty (any type of flap or technique is allowed).
  • Sexually active or has been sexually active since phalloplasty or metoidioplasty with a partner or main sexual partner.
  • Voluntarily agreed that the data may be used for an anonymized scientific study.
Not Eligible

You will not qualify if you...

  • Patient age < 18 years.
  • Cisgender patients treated with phalloplasty or metoidioplasty for various reasons.
  • Less than 6 months after phalloplasty or metoidioplasty.
  • Not sexually active since phalloplasty/metoidioplasty.
  • Patient and/or partner have no interest in penetrative sexual intercourse.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Department of Urology, University Hospital Ghent

Ghent, East-Flanders, Belgium, 9000

Actively Recruiting

Loading map...

Research Team

W

Wietse Claeys, MD

CONTACT

A

Anne-Françoise Spinoit, MD, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here